Gene Editing

ERS Genomics holds an exclusive worldwide license from Dr. Charpentier to the foundational patents covering CRISPR/Cas9

Scientists describe how the levels of beta-glucan in barley grain can be influenced through gene editing

New enzyme provides a powerful new tool in the CRISPR genome editing toolbox, because it can target a wider range of genetic sequences compared to Cas9 and Cas12

New method could produce better seeds compared with conventional hybrid methods and shorten the production timeline by five to 10 years

Computational models based on deep learning predict the activities of SpCas9 variants and provide a useful guide for selecting the most appropriate one

Because of the urgency to get new tests, therapies, and preventions into the clinic amid a pandemic, many of these approaches are undergoing a trial by fire

Heparin is a potent anti-coagulant and the most prescribed drug in hospitals, yet cell-culture-based production of heparin is currently not possible

Clifford J. Steer, MD, discusses the changes that have taken place in genomics since the sequencing of the human genome in this Q&A with  contributing editor Tanuja Koppal, PhD

New data on first-in-US trial sheds new light on success of gene editing and cell function